Please provide your email address to receive an email when new articles are posted on . Researchers identified no link between vaginal estrogen tablet use and recurrent stroke risk. The findings did ...

Hormone replacement therapy using vaginal estrogen tablets was not associated with an increased risk of ischemic stroke for postmenopausal women who have already had a stroke, according to a data ...

Vaginal atrophy is a condition that can negatively impact the quality of life of many postmenopausal women. Local exogenous estrogen therapy can effectively alter the anatomic and pathophysiologic ...

In Danish women with a history of ischemic stroke, use of vaginal estradiol tablets was not associated with an increased rate of recurrent ischemic stroke. Results suggest these women may not be so ...

ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of Conjugated Estrogens Tablets, USP, ...

Choice of therapy is based on patient needs and preferences. Some patients find dosing of the cream confusing. Active estrogen cream dosing is specified in milligrams, the dose of base cream is in ...

Women with breast cancer who use vaginal estrogen therapies, such as tablets or creams, do not face an increased risk for breast cancer–specific mortality, which can provide some reassurance to ...

Women of reproductive age are more likely than other people to report gut problems like irritable bowel syndrome (IBS), and can feel dismissed by doctors, as clinicians often put the pain down to diet ...

Although both sexes normally secrete some female hormones (estrogens) from birth until death, by far the heaviest output is among women who are old enough to bear children. From early teens to the ...